Articles

Sequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations

Ocuphire Pharma and Viatris developed the drug together for the reversal of pharmacologically-induced mydriasis (RM) produced by adrenergic agonist or parasympatholytic agents

Attendees can take advantage of many satellite symposia, sponsored by industry and feauring experts from around the world

Experts in all aspects of retinal care will gather at the RAI Amsterdam Convention Centre, located in the Zuidas business district of the city, which is a short distance from historic Amsterdam with is canals, museums, and shops

Research from Orbis International analyses the overall wellbeing of children with common childhood vision problems

Stem cells may replace some lost retinal neurons

The AI retinal scanning model will be free to use for all institutions

MERCURY-3 trial data show latanoprost/netarsudil fixed-dose combination (Roclanda) demonstrated comparable IOP lowering efficacy to bimatoprost/timolol combination, in patients with primary open-angle glaucoma or ocular hypertension.

Novartis acquired Gyroscope Holdings Limited from Syncona in February 2022

According to Bausch + Lomb, MIEBO (perfluorohexyloctane ophthalmic solution), commercialised as EvoTears in Europe, is the first prescription eye drop that targets tear evaporation.

The company has 9 presentations at the annual congress of the European Society of Cataract and Refractive Surgeons being held in Vienna. AVG also is a sponsor of the International Society of Presbyopia.

OWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.

The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.

The company announced new data on outcomes for both open and narrow angle glaucoma patients.

Reviewing visual and anatomic outcomes in 2 clinical trials

Lenticule extraction poses a provocative question–and a complicated answer

According to the company, the deal expands its European footprint into Spain and Portugal.

One of AI’s most promising applications: new diagnostic algorithms

Advancements from Carl Zeiss Medical AG in the cataract and cornea space include a new intraocular lens and therapeutic laser enhancements.

The new platform incorporates the SILK procedure, allowing surgeons to perform refractive correction on patients with myopia.

The EUREQUO Annual Report celebrates 15 years and over 4 million surgical procedures in the registry.

According to the company, it is working with the FDA to address the agency’s issues.

ATSN-201 leverages novel spreading capsid to overcome challenges associated with intravitreally delivered AAVs in the treatment of XLRS.

OCT methods are invaluable in the assessment of patients with the condition

Commonly used immunosuppressants used in the short term to control an ocular inflammatory disease were not associated with increased risk of developing cancer later.

Surgeon discusses latest trends for treating cornea

This intellectual property protects Kiora's pipeline by covering several inflammatory-related therapeutic applications, including posterior non-infectious uveitis.

A multicentre study demonstrates comparable results to FS-LASIK

VG901 is a gene therapy for CNGA1-associated RP.